KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Gains from Investment Securities (2017 - 2025)

Historic Gains from Investment Securities for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to $24.8 million.

  • Twist Bioscience's Gains from Investment Securities rose 685870.79% to $24.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $22.2 million, marking a year-over-year increase of 15018.75%. This contributed to the annual value of -$2.2 million for FY2025, which is 9509.68% up from last year.
  • According to the latest figures from Q4 2025, Twist Bioscience's Gains from Investment Securities is $24.8 million, which was up 685870.79% from -$240000.0 recorded in Q3 2025.
  • Twist Bioscience's 5-year Gains from Investment Securities high stood at $33.5 million for Q2 2021, and its period low was -$44.1 million during Q2 2024.
  • In the last 5 years, Twist Bioscience's Gains from Investment Securities had a median value of -$240000.0 in 2025 and averaged $1.5 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first surged by 15108333.33% in 2022, then tumbled by 91413.02% in 2024.
  • Quarter analysis of 5 years shows Twist Bioscience's Gains from Investment Securities stood at $10.4 million in 2021, then tumbled by 104.79% to -$499000.0 in 2022, then surged by 37.47% to -$312000.0 in 2023, then surged by 214.1% to $356000.0 in 2024, then skyrocketed by 6858.71% to $24.8 million in 2025.
  • Its Gains from Investment Securities stands at $24.8 million for Q4 2025, versus -$240000.0 for Q3 2025 and -$1.2 million for Q2 2025.